Purpose: To compare patients with palsy of the 3rd, 4th or 6th cranial nerve due to diabetes mellitus (DM) with controls matched for age, sex and disease duration in terms of the presence and severity of diabetic retinopathy. Patients and Method: Thirty-three diabetic patients with cranial nerve palsies and 33 age- and sex-matched controls with the same duration of disease were included in this case-control study. Groups were evaluated in terms of the type of DM, presence and level of diabetic retinopathy and coexisting systemic diseases. Outcomes were compared by χ2 and paired-sample tests. Results: Eleven patients had diabetic retinopathy in the study group. In the control group, 23 patients had diabetic retinopathy. Differences in the presence and severity of diabetic retinopathy between the two groups were found to be statistically significant (p = 0.028 and p = 0.018, respectively). Conclusion: Presence and level of diabetic retinopathy are significantly lower in diabetics with cranial nerve palsy than in the age-, sex- and disease-duration-matched controls.

1.
Richards BW, Jones FR Jr, Younge BR: Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol 1992;113:489–496.
2.
Watanabe K, Hagura R, Akanuma Y, et al: Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 1990;10:19–27.
3.
Zorrilla E, Kozak P: Ophthalmoplegia in diabetes mellitus. Ann Intern Med 1967;67:968–976.
4.
Dominquez D, Temesio P, Gomensoro J, et al: Diabetic ophthalmoplegia. Acta Diabetol Lat 1974;11:198–205.
5.
Eshbaugh CG, Siatkowski RM, Smith JL, et al: Simultaneous, multiple cranial neuropathies in diabetes mellitus. J Neuroophthalmol 1995;15:219–224.
6.
Trigler L, Siatkowski M, Oster AS, et al: Retinopathy in patients with diabetic ophthalmoplegia. Ophthalmology 2003;110:1545–1550.
7.
Weber RB, Daroff RB, Mackey EA: Pathology of oculomotor nerve palsy in diabetics. Neurology 1970;20:835–838.
8.
Lazzaroni F, Laffi G, Galuppi V, Csorolli L: Paralysis of oculomotor nerves in diabetes mellitus: a retrospective study of 44 cases. Rev Neurol (Paris) 1993;149:571–573.
9.
Zrustova M, Vrabec F, Rostlapil J: Diabetic changes of the extra-ocular muscles in man. Acta Diabetol Lat 1979;16:55–62.
10.
Asbury AK, Aldredge H, Hershberg R, et al: Oculomotor palsy in diabetes mellitus: a clinico-pathologic study. Brain 1970;93:555–566.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.